Lanzamiento Enero 2027

Ensayo controlado aleatorizado2019Financiación no declarada

Proteinuria-associated renal magnesium wasting leads to hypomagnesemia: a common electrolyte abnormality in chronic kidney disease

Oka T, Hamano T, Sakaguchi Y, Yamaguchi S, Kubota K, Senda M, Yonemoto S, Shimada K, Matsumoto A, Hashimoto N, Mori D, Monden C, Takahashi A, Obi Y, Yamamoto R, Takabatake Y, Kaimori JY, Moriyama T, Horio M, Matsui I, Isaka Y

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 50 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2018-04-12 · Nephrol Dial Transplant · vol. 34 · número 7 · págs. 1154–1162
Editorial
Oxford University Press
Citado
72 citas · más que el 92% de estudios similares · 3.1× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
41 trabajos
Acceso
De pago
Áreas de investigación
Magnesium in Health and Disease · Parathyroid Disorders and Treatments · Potassium and Related Disorders
Palabras clave
Medicine, Proteinuria, Internal medicine, Kidney disease, Hypomagnesemia, Gastroenterology, Odds ratio, Endocrinology, Creatinine, Urology, Kidney, Magnesium
MeSH
humans, renal tubular transport, inborn errors, proteinuria, disease progression, electrolytes, magnesium, magnesium oxide, kidney function tests, prevalence, retrospective studies, follow-up studies, cross-sectional studies, adult, middle aged, outpatients, japan, female, male, renal insufficiency, chronic, biomarkers

21 autores

  • Tatsufumi Oka🇯🇵The University of Osaka
  • Takayuki Hamano🇯🇵 · autor de correspondenciaThe University of Osaka
  • Yusuke Sakaguchi🇯🇵The University of Osaka
  • Satoshi Yamaguchi🇯🇵The University of Osaka
  • Keiichi Kubota🇯🇵The University of Osaka
  • Masamitsu Senda🇯🇵The University of Osaka
  • Sayoko Yonemoto🇯🇵The University of Osaka
  • Karin Shimada🇯🇵The University of Osaka
  • Ayumi Matsumoto🇯🇵The University of Osaka
  • Nobuhiro Hashimoto🇯🇵The University of Osaka
  • Daisuke Mori🇯🇵The University of Osaka
  • Chikako Monden🇯🇵Osaka Kaisei Hospital
  • Atsushi Takahashi🇯🇵The University of Osaka
  • Yoshitsugu Obi🇺🇸University of California, Irvine
  • Ryohei Yamamoto🇯🇵Osaka Health Science University; The University of Osaka
  • Yoshitsugu Takabatake🇯🇵The University of Osaka
  • Jun-Ya Kaimori🇯🇵The University of Osaka
  • Toshiki Moriyama🇯🇵Osaka Health Science University; The University of Osaka
  • Masaru Horio🇯🇵The University of Osaka
  • Isao Matsui🇯🇵The University of Osaka
  • Yoshitaka Isaka🇯🇵The University of Osaka

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Hypomagnesemia (Hypo-Mg) predicts mortality and chronic kidney disease (CKD) progression. However, in CKD, its prevalence, kidney-intrinsic risk factors, and the effectiveness of oral magnesium (Mg) therapy on serum Mg levels is uncertain.

Methods

In a cross-sectional study enrolling pre-dialysis outpatients with CKD, the prevalence of electrolyte abnormalities (Mg, sodium, potassium, calcium and phosphorus) was compared. In an open-label randomized controlled trial (RCT), we randomly assigned CKD patients to either the magnesium oxide (MgO) or control arm. The outcome was serum Mg levels at 1 year.

Results

In 5126 patients, Hypo-Mg was the most common electrolyte abnormality (14.7%) with similar prevalence across stages of CKD. Positive proteinuria was a risk factor of Hypo-Mg (odds ratio 2.2; 95% confidence interval 1.2-4.0). However, stratifying the analyses by diabetes mellitus (DM), it was not significant in DM (Pinteraction = 0.04). We enrolled 114 patients in the RCT. Baseline analyses showed that higher proteinuria was associated with higher fractional excretion of Mg. This relationship between proteinuria and renal Mg wasting was mediated by urinary tubular markers in mediation analyses. In the MgO arm, higher proteinuria or tubular markers predicted a significantly lower 1-year increase in serum Mg. In patients with a urinary protein-to-creatinine ratio (uPCR) <0.3 g/gCre, serum Mg at 1 year was 2.4 and 2.0 mg/dL in the MgO and control arms, respectively (P < 0.001), with no significant between-group difference in patients whose uPCR was ≥0.3 g/gCre (Pinteraction=0.001).

Conclusions

Proteinuria leads to renal Mg wasting through tubular injuries, which explains the high prevalence of Hypo-Mg in CKD.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.